Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 196

Related Citations for PubMed (Select 22432708)

1.

Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.

Müller A, Ulm H, Reder-Christ K, Sahl HG, Schneider T.

Microb Drug Resist. 2012 Jun;18(3):261-70. doi: 10.1089/mdr.2011.0242. Epub 2012 Mar 20.

PMID:
22432708
2.

Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.

Wiedemann I, Böttiger T, Bonelli RR, Schneider T, Sahl HG, Martínez B.

Appl Environ Microbiol. 2006 Apr;72(4):2809-14.

3.

An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.

Hasper HE, Kramer NE, Smith JL, Hillman JD, Zachariah C, Kuipers OP, de Kruijff B, Breukink E.

Science. 2006 Sep 15;313(5793):1636-7.

4.

Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.

Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G, de Kruijff B, Sahl HG.

J Biol Chem. 2001 Jan 19;276(3):1772-9. Epub 2000 Oct 18.

5.

Antimicrobial mechanism of lantibiotics.

Islam MR, Nagao J, Zendo T, Sonomoto K.

Biochem Soc Trans. 2012 Dec 1;40(6):1528-33. doi: 10.1042/BST20120190. Review.

PMID:
23176511
6.

Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics.

Brötz H, Josten M, Wiedemann I, Schneider U, Götz F, Bierbaum G, Sahl HG.

Mol Microbiol. 1998 Oct;30(2):317-27.

PMID:
9791177
7.

Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.

Hsu ST, Breukink E, de Kruijff B, Kaptein R, Bonvin AM, van Nuland NA.

Biochemistry. 2002 Jun 18;41(24):7670-6.

PMID:
12056898
8.

Mode of action of lipid II-targeting lantibiotics.

Bauer R, Dicks LM.

Int J Food Microbiol. 2005 May 25;101(2):201-16. Review.

PMID:
15862882
9.

Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.

Bonelli RR, Schneider T, Sahl HG, Wiedemann I.

Antimicrob Agents Chemother. 2006 Apr;50(4):1449-57.

10.

Membrane lipids determine the antibiotic activity of the lantibiotic gallidermin.

Christ K, Al-Kaddah S, Wiedemann I, Rattay B, Sahl HG, Bendas G.

J Membr Biol. 2008 Nov-Dec;226(1-3):9-16. doi: 10.1007/s00232-008-9134-4. Epub 2008 Nov 14.

PMID:
19009315
11.

Targeting extracellular pyrophosphates underpins the high selectivity of nisin.

Bonev BB, Breukink E, Swiezewska E, De Kruijff B, Watts A.

FASEB J. 2004 Dec;18(15):1862-9.

12.

Elucidation of the antimicrobial mechanism of mutacin 1140.

Smith L, Hasper H, Breukink E, Novak J, Cerkasov J, Hillman JD, Wilson-Stanford S, Orugunty RS.

Biochemistry. 2008 Mar 11;47(10):3308-14. doi: 10.1021/bi701262z. Epub 2008 Feb 12.

PMID:
18266322
13.

Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics.

de Kruijff B, van Dam V, Breukink E.

Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):117-21. doi: 10.1016/j.plefa.2008.09.020. Epub 2008 Nov 12. Review.

PMID:
19008088
14.

Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5.

Paiva AD, Breukink E, Mantovani HC.

Antimicrob Agents Chemother. 2011 Nov;55(11):5284-93. doi: 10.1128/AAC.00638-11. Epub 2011 Aug 29.

15.

Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria.

Héchard Y, Sahl HG.

Biochimie. 2002 May-Jun;84(5-6):545-57. Review.

PMID:
12423799
16.

Assembly and stability of nisin-lipid II pores.

Hasper HE, de Kruijff B, Breukink E.

Biochemistry. 2004 Sep 14;43(36):11567-75.

PMID:
15350143
17.

Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane.

Wenzel M, Kohl B, Münch D, Raatschen N, Albada HB, Hamoen L, Metzler-Nolte N, Sahl HG, Bandow JE.

Antimicrob Agents Chemother. 2012 Nov;56(11):5749-57. doi: 10.1128/AAC.01380-12. Epub 2012 Aug 27.

18.

Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic.

Islam MR, Nishie M, Nagao J, Zendo T, Keller S, Nakayama J, Kohda D, Sahl HG, Sonomoto K.

J Am Chem Soc. 2012 Feb 29;134(8):3687-90. doi: 10.1021/ja300007h. Epub 2012 Feb 17.

PMID:
22329487
19.

Lipid II as a target for antibiotics.

Breukink E, de Kruijff B.

Nat Rev Drug Discov. 2006 Apr;5(4):321-32. Review.

PMID:
16531990
20.

Aggregates of nisin with various bactoprenol-containing cell wall precursors differ in size and membrane permeation capacity.

Scherer K, Wiedemann I, Ciobanasu C, Sahl HG, Kubitscheck U.

Biochim Biophys Acta. 2013 Nov;1828(11):2628-36. doi: 10.1016/j.bbamem.2013.07.014. Epub 2013 Jul 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk